Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2015; 47(1): 119-128


Adverse Effects of Ivermectin in comparison with Rafoxanide on Male Rats

Abd El-Salam F. El-Sawy, Zeynab Kh. El-Maddawy and Soaad A. Seed.




Abstract

The present study was conducted to evaluate the effect of Ivermectin and /or Rafoxanide on male fertility, as well as their effects on the liver and kidney functions tests, some hematological parameters and histopathological changes. Sixty mature male rats were used and divided into 4 equal groups. The first group was kept as control and subcutaneously injected with proplyene glycol (2ml/kg b.wt. s,c) and were given distilled water at dose of 2ml/kg b.wt .orally . The second group was injected with Ivermectin at a dose of( 0.56 mg/kg bwt s.c). The third group was given Rafoxanide( 7.5 mg / kg bwt orally) .The fourth group was injected with Ivermectin (o.56mg/kg b.w. s.c) together with (Rafoxanide 7.5mg/kg b.w oral), All drugs were readministered to all groups after 30 days from the start of the experiment as the same doses previously mentioned. Five rats from each treated and control group were killed after 2 ,4 ,8 weeks from the beginning of drug administration .The obtained results showed that administration of Ivermectin and /or Rafoxanide induced a variety of side effects on male reproduction as reduction of testes, epididymis, and accessory sex organs weights and change in sperm characters; decease of sperm count and motility, and increase in sperm abnormalities. Liver functions testes values such as Serum alanine aminotransferase (ALT) and aspartate aminotransferase(AST) and alkaline phosphatase (AlP) were significantly increased. Moreover, administration of Ivermectin and/ or Rafoxanide induced histopathological alterations in reproductive organs, liver and kidney tissues .

Key words: Ivermectin , Rafoxanide,male fertility, liver&kidney function,blood






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.